Here, doctors explain which COVID-19 vaccine is better when comparing Moderna, Pfizer, and Novovax. Plus, the efficacy of ...
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
Moderna has been rebuked by regulators after offering children cash to test the Covid vaccine ...
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
New COVID-19 vaccines reached about 395,000 New Yorkers, or 3.5%, so far in fall 2024, as health officials push to reverse a trend of limited uptake of the shots despite their proven effectiveness at ...